risks with glp 1 GLP-1 medications linked to major drop in pancreatic, colorectal cancer risk https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1-slash-risk -4-types-cancer-50-or-more-study Risk of pancreatic cancer associated

Transforming Lives, One Step at a Time Keep reading Mons Pubis Fat Loss on GLP-1s: The Pubic Area Change Nobody Mentions One change that surprises people on GLP-1 medications rarely comes up in conversation: the mons pubis, the soft fat pad over the pubic bone, How to Adjust Weight Loss Goals on GLP-1 Medications Adjust weight goals on GLP-1 meds by tracking body composition and labs, optimizing protein, activity, sleep, and working with your provider on dosing

Procedures requiring anesthesia Because these medications delay gastric emptying, some anesthesia and procedural guidelines recommend holding GLP-1 medications before procedures to reduce aspiration risk

Omega-3 Fatty Acids Omega-3 fatty acid can be a valuable addition to a GLP-1 supplement routine because they support overall metabolic health while also helping with areas many women care about during weight loss, including inflammation balance, cardiovascular health, and brain function

Best JH, Hoogwerf BJ, Herman WH, Pelletier EM, Smith DB, Wenten M, Hussein MA: Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database

Monjouro/Zepbound is a GIP (glucose-dependent insulinotropic polypeptide) and GLP - 1 receptor agonist